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This thesis establishes and validates an experimental animal model to analyse 
leukocyte recruitment and microvascular dysfunction in pulmonary 
ischemia/reperfusion injury by intravital fluorescence microscopy in the rat. 
 The pleural surface of the rat left lung has been exposed by atraumatic 
microsurgical techniques and fluorescence epi-illumination was used to visualize 
subpleural pulmonary microcirculation under baseline conditions and during 
reperfusion after 30 min of ischemia. 
The results show that this experimental setup bears the required spatial and 
temporal resolution to study postischemic leukocyte responses within the pulmonary 
microcirculation. All segments of pulmonary microvascular tree can be differentially 
analysed, including feeding arterioles, alveolar capillaries and draining postcapillary 
venules. The data analyses demonstrate that the relatively mild ischemic insult of 30 
min provokes a detectable leukocytic response, i.e. significantly increased leukocyte- 
endothelial cell adhesive interactions in postcapillary subpleural pulmonary venules 
during reperfusion. Microhemodynamics were not significantly altered during 
reperfusion. These results translate into the histopathological analyses, confirming mild 
affection of the pulmonary tissue structures after 90 min of reperfusion. Confirming i) 
the relatively mild ischemic insult to the lung and ii) virtual absence of trauma by the 
microsurgical preparations, remote organ damage was basically absent the heart and 
kidney, but only minimally seen in the liver. 
In conclusion, the established experimental setup allows for reproducible 
analyses pulmonary ischemia/reperfusion injury on the microcirculatory level in the rat 
lung. The use of this basic approach may serve as a reliable basic model for further 
studies on pulmonary ischemia/reperfusion injury and experimental allo- and 




Im Rahmen dieser Promotionsarbeit wird ein tierexperimentelles Modell zur Analyse 
von Leukozytenrekrutierung und mikrovaskulärer Dysfunktion während pulmonalem 
Ischämie/Reperfusionsschaden mittels intravitaler Fluoreszenzmikroskopie in der 
Ratte etabliert und evaluiert. 
Die pleurale Oberfläche der linken Lunge wird durch atraumatischen 
mikrochirurgischen Techniken exponiert. Mittels Fluoreszenz-epi-Illumination wird 
die subpleurale Mikrozirkulation der Lunge unter Basisbedingungen und während 
Reperfusion nach einer 30 minütigen Ischämie visualisiert. 
Die Ergebnisse zeigen, dass der experimentelle Ansatz die notwendige räumliche und 
zeitliche Auflösung besitzt, um die postischämische Leukozytenantwort in der 
pulmonalen Mikrozirkulation darzustellen. Alle Segmente der pulmonalen 
mikrovaskulären Strombahn können differenziert analysiert werden. Dies beinhaltet 
zuführe nde Arteriolen, alveoläre Kapillaren und drainierende postkapilläre Venolen. 
Die Datenanalyse zeigt, dass der relative milde 30-minütige, ischämische Insult eine 
detektierbare Leukozytenantwort provoziert, d.h. significant erhöhte Leukozyten - 
Endothelzell Adhäsionen in postkapillären pulmonalen Venolen während Reperfusion. 
Die Mikrohämodynamik war nicht significant beeinträchtigt während Reperfusion. 
Diese Ergebnisse übersetzen sich in die histopathologische Analysen, eine milde 
Affektion der Lungengewebestruktur nach 90 Minuten Reperfusion bestätigen. 
Sekundäre Organschäden in Herz und Niere wurden nicht detektiert und waren nur 
milde ausgeprägt in der Leber zu finden, was einerseits die relative Milde der 
Lungenischämie und andererseits die nahezu atraumati schen mikrochirurgische 
Präparationen bestätigt. 
Zusammenfassend erlaubt der experimentelle Ansatz eine reproduzierbare Analyse des 
Ischämie/Reperfusionsschadens in der Rattenlunge auf mikrovaskulärer Ebene. Dieser 
Ansatz kann als zuverlässiges experim entelles Basismodell für weitergehende 
Untersuchungen des Ischämie/Reperfusionsschadens in der Lunge, sowie allo - und 




3.1. Lung transplantation 
 
Lung transplantation has become a valid option in the treatment of end-stage 
lung diseases, refractory to any other medical and/or surgical therapy [1]. Since the first 
successful clinical transplantation of a donor lung in 1963, the results after lung 
transplantation for end-stage lung disease have steadily improved. Most recent data 
indicate a median survival after lung transplantation of 6.7 years and a 1-year survival 
of 8.9 years [2]. The improved outcome has been achieved by refinements of surgical 
techniques, e.g. periprocedural use of extracorporeal circulation [3], and advances in 
immunosuppressive therapy, e.g. introduction of calcineurin inhibitors [4, 5]. Despite 
all these advances, survival after lung transplantation is still limited and the overall 
results are far from perfect. 
Transplanted lung allografts are damaged in the postoperative and long-term 
course by several mechanisms (Figure 1). Such include the ischemia/reperfusion injury 
mediated by the unspecific innate immunity, as well as acute and chronic rejections 
through specific adaptive immune responses [5, 6]. In addition, donor-specific 
antibody-mediated rejection episodes may occur, although there is only limited 
understanding of when and how this entity of post lung transplant organ injury develops 
and works [7]. Regarding the continuous deterioration of graft function post-transplant, 
it is a well-established understanding that ischemia/reperfusion injury occurs within the 
first days after transplantation, while acute cellular rejection episodes may occur at 
different time points longer-term. However, the highest incidence of acute cellular 
rejection episodes is within the first 6 to 12 months after lung transplantation [2]. The 
detailed mechanisms underlying chronic lung allograft rejection are not completely 
understood at present, but it manifests clinically in steadily declining lung function test 
parameters and the pathophysiologic correlate is a fibrotic swelling of the terminal 
bronchioli, previously designated as the bronchiolitis obliterans syndrome. However, 
more recent definitions of the chronic lung allograft dysfunction (CLAD) further 
differentiate between more obstructive or restrictive functional and structural 




Figure 1: Lung injury after transplantation. The function of a transplanted lung allograft 
is at risk during the early postoperative period due to ischemia/reperfusion injury 
provided by the innate immune system. The specific and adaptive immune responses 
trigger the frequency and intensity of acute rejection episodes as well as chronic 
rejection determining the outcome of lung transplantation long-term. 
 
 




The magnitude of the injurious net effect following ischemia during reperfusion 
primarily depends on and is proportionate to the duration of the anoxic phase following 
organ retrieval, during transportation and implantation into the recipient [9, 10]. It has 
been well recognized that tolerance of transplanted organs towards ischemia can be 
improved by vigorous organ cold preservation, i.e. the organs are perfused in the donor 
by a chilled preservation solution at the time of retrieval and are transported on ice to 
the recipient operation. This applies also to lung allografts, in which colloidal, buffered 
electrolyte solutions are used [11, 12]. However, despite improved procurement 
techniques and optimal preservation measures, the ischemic time of a lung allograft 
must not be extended over a maximum of 9 to 12 hours [13, 14], because this would 
significantly endanger a positive outcome of the transplant procedure. 
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The transplantation of a lung allograft differs to a certain extend from other solid 
organ transplantations as the nutritive arterial vasculature is not connected to the 
recipients circulation. Only pulmonary arteries carrying deoxygenated blood to the lung 
are anastomosed. Drainage of blood is conducted through the pulmonary veins into the 
recipients left atrium. Bronchial arteries derived from the systemic blood stream are not 
anastomosed [15]. It has been suggested that this reasons, why mainly the bradytroph 
bronchial tissue is at risk during severe ischemia/reperfusion injury of the lung after 
transplantation, potentially leading to impaired healing of the anastomosed bronchi or 
even necrotising disruption of this fragile airway connection [15, 16]. 
Ischemia/reperfusion injury has been considered to manifest clinically as the 
primary graft dysfunction (PGD) after lung transplantation. It has a reported incidence 
of between 10%-30% and is a major cause of death in early post-transplantation days 
[17-19]. According to the 34th report of the registry of the International Society for 
Heart and Lung Transplantation (ISHLT), PGD is one major reason of death within the 
first 30 days of transplantation [4]. The ISHLT proposed a clinical definition of PGD 
and that is the presence of hypoxemia and radiographic appearance of diffuse 
pulmonary opacities in post-transplant chest X-rays without other identifiable causes 
within the first 72 hours after surgery. Its severity is judged clinically depending on the 
ratio of arterial oxygen fraction (PaO2) per inspired oxygen fraction (FiO2) [20]. It 
remains under discussion whether machine perfusion techniques during transportation 
of the allograft and the corresponding limitation of the anoxic phase may blunt 
ischemia/reperfusion injury after transplantation and thereby improve postoperative 
outcomes [21]. There are some indicator suggesting that such techniques may reduce 








The absence of nutritive arterial perfusion with oxygenated blood during 
ischemia leads to a depression of mitochondrial energy production and a depletion of 
adenosine triphosphate. This affects the intracellular ion homeostasis and cellular 
membrane permeability. Cellular necrosis and activation of apoptotic cell signals may 
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follow [23]. In addition, the fall in cellular energy content activates self-propagating 
deleterious cascades [23]. It is directly related to the production of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS). Their production is induced during 
ischemia [24] and will increase rapidly during reperfusion [25]. Among all the potential 
sources and the formation pathways of ROS and RNS within cells, xanthine oxidases, 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, and nitric oxide 
synthases (NOS) have been investigated [26]. 
Reperfusion of a transplanted allograft starts with the release of blood flow from 
the donor pulmonary trunc, passing the pulmonary arterial anastomosis into the grafts’ 
pulmonary arterial vascular tree. The start of reperfusion is the restoration of blood flow 
in a previously anoxic graft, but it is at the same time the onset of microvascular 
perfusion failure within the grafted tissue [6]. The so-called “no reflow phenomenon” 
exacerbates hypoxia/anoxia in the grafted tissue despite the macroscopic restitution of 
the grafts blood circulation. The phenomenon describes the post-ischemic collapse of 
the graft’s microcirculation due to endothelial cell swelling, hemoconcentration, 
narrowing of nutritive capillaries and interstitial edema formation [27-30]. 
Ischemia/reperfusion injury of a transplanted graft is an inflammatory response, an 
unspecific reaction rather than a cognitive response. The inflammatory response during 
ischemia reperfusion is a sterile process, which is activated by sterile cell death or injury. 
It has been confirmed that receptors, such as Toll-like receptors (TLRs) and DAPMs 
play a central roles in such immune response [31, 32]. When ligands bind to TLRs, cell 
signal pathways, such as NF-kB, mitogen-activated protein kinase (MAPK) and type I 
interferon pathways are activated, leading to the formation of pro-inflammatory 
mediators, such as cytokines and chemokines [33]. Neutrophils, monocytes and 
macrophages exert complementary functions during inflammation, also in the lung [34]. 
It is thought that, after stimulation, tissue resident macrophages and sentinel monocytes 
release chemokines and pro-inflammatory cytokines to recruit circulating white blood 
cells, primarily polymorphonuclear leukocytes, into the inflamed tissue compartment. 
Neutrophil infiltration and granule release is followed by monocyte recruitment in a 
secondary phase. 
The early activation of alveolar macrophages via TLR-4 is thought to play a 
critical role in the development of lung ischemia/reperfusion injury [35, 36]. It has 
been shown that there was a significant increase in the number of alveolar macrophages 
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in bronchi-alveolar lavage fluid (BALF) after one hour hypoxia [37]. Using a murine 
lung transplantation model, it was shown that depletion of donor macrophages 
attenuated ischemia/reperfusion injury [38]. Suppressing of TLR-4 signalling inhibited 
the activation of alveolar macrophage as well and lung ischemia/reperfusion injury was 
almost completely attenuated [39]. Due to oxidative stress, alveolar macrophages 
produce monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory 
protein-2 (MIP-2) which contribute to infiltration of neutrophils and lead to pulmonary 
oedema [40]. Beside this, macrophages can release tumour necrosis factor-α (TNF-α), 
one of the pro-inflammation cytokines which can lead to acute lung damage directly 
[41]. In a rabbit lung ischemia/reperfusion injury model, TNF-α rose continuously 
during reperfusion and by attenuation TNF-α, the alveolar cell apoptosis and acute lung 
injury could be inhibited [42]. 
Also monocytes have been suggested to be involved in pulmonary 
ischemia/reperfusion injury. Classical monocytes are considered to be pro- 
inflammatory, since they can produce pro-inflammatory cytokines and differentiate into 
macrophages and dendritic cells [43]. In a model of lung ischemia/reperfusion injury, 
classical monocytes were found to be mobilized from their natural reservoir in the 
spleen, to enter into pulmonary tissue and provoke subsequent neutrophilic infiltration 
into the lung by releasing IL-1β [44]. Non-classical monocytes are thought to regulate 
wound healing and the resolution of inflammation. As such, they may be important 
mediators in lung injury as well. It was shown in a murine lung transplantation model 
that the depletion of donor intravascular non-classical monocytes, both 
pharmacologically and genetically, attenuated lung graft injury [45]. However, the 
precise role of non-classical monocytes, particularly in lung ischemia/reperfusion 
injury is still unclear [44]. 
The recruitment of circulating polymorphonuclear leukocytes (PMNLs), i.e. 
neutrophils, is a paramount feature of ischemia/reperfusion injury. This has been 
studied extensively in various organs such as the liver, striated muscle, intestine, kidney 
and the heart [46-49]. 
There has been conflicting data on the role of neutrophils in pulmonary 
ischemia/reperfusion injury. Neutrophils were initially thought to be unnecessary in 
lung ischemia/reperfusion injury [50, 51]. However, it was postulated that lung 
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ischemia/reperfusion injury has distinct phases [52, 53]. There seems to be an early 
phase, which is independent of neutrophils, while neutrophilic infiltration occurs later 
and is associated with increased pulmonary vascular permeability. Obviously, the 
activation of the pulmonary microvascular endothelium is a crucial part for the 
recruitment of neutrophils during lung ischemia/reperfusion injury. It is induced by 
TNF-α, IL-1β and will lead to an up-regulation of certain adhesion molecules on the 
luminal surface of the pulmonary vascular endothelium [54]. The recruitment of blood- 
borne white blood cells into the lung has been suggested to follow the same pattern of 
neutrophil recruitment in other organs (Figure 2). Neutrophils are thought to roll along 
the activated pulmonary endothelial surface orchestrated by a cytokine gradient and 
mediated by adhesion molecules of the selectin family, i.e. P- and/or L-selectin on 
neutrophils binding to E-selectin on the pulmonary endothelial surface. Further 
activation of the rolling cell will slow it down and more firm attachment is then 
mediated by the integrin family o f adhesion molecules. The final step is the 
transendothelial migration. It is unknown, however, whether the transmigrating cell 
passes the endothelial lining between or directly through the endothelial cells [54]. The 
number of infiltrated neutrophils correlates to the severity of tissue damage [55]. By 
reducing the alveolar infiltration of neutrophils in a rat lung transplantation model, the 
gas exchange after surgery was improved [56]. It was thought that neutrophils exert 
lung ischemia/reperfusion injury by releasing elastase and granular proteins [57]. 
Neutrophil extracellular trap is an extracellular complex, including DNA, histones and 
neutrophil granular proteins [58]. Caudrillier et al found that neutrophil extracellular 
traps were created during lung transfusion and related to acute lung injury [59]. It was 
further shown that the neutrophil extracellular traps accumulated and contribute to 





Figure 2: Schematic sequence of leukocyte recruitment in a microvessel. The 
extravasation of circulating leukocytes during inflammation may be defined as a 
sequential cascade of events including (A) free flowing, B) rolling, C) activation, D) 
firm adhesion and, finally, E) transmigration of inflammatory cells. Blood flow is from 
left to right. (The use if this figure has kindly been granted by Rene Schramm, Heart 
and Diabetes Center NRW, Bad Oeynhausen, Germany) 
 
 
Despite these lines of evidence strongly suggesting that circulating leukocyte 
recruitment from the pulmonary vasculature is a key feature in lung 
ischemia/reperfusion injury, it has to be noted that the underlying evidence has been 
gathered only indirectly. Direct visualization of the pulmonary microvasculature during 
reperfusion has not been performed. It has to be considered also that the so- called 
marginated pool of leukocytes, i.e. a large number of granulocytes residing in the lung 
under normal physiological conditions, may have affected the results of previous 
studies [61-63]. 
Ischemia/reperfusion injury can affect platelet function and the coagulation 
system due to ROS induced increases in extracellular adenosine di-phosphate 
concentrations and endothelial cell injury induced activation of the von Willebrand 
factor (vWF) and thrombin [64-66]. Activated platelets may also interact directly with 
endothelial cells via selectins, which has been shown to cause microvascular 
constriction, aggravate postischemic injury and lead to thrombus formation [10]. P- 
selection can regulate platelet-endothelium interaction and promote platelet-leukocyte 
interaction during ischemia/reperfusion injury [67]. Finally, activated platelets form 
microthrombi perpetuating endothelial cell injury and microvascular dysfunction [68]. 
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Microvascular permeability is increased because of hypoxia during reperfusion, 
triggered by the rapid production of ROS, complement activation, leucocyte- 
endothelial cell adhesion and platelet-leucocyte aggregation [6, 69]. In lungs, it presents 
as the alveolar-capillary barrier dysfunction which can lead to pulmonary edema and 
ultimately induces respiratory failure [70]. Vascular endothelial growth factor and 
angiopoietin-2 are considered as mediators of vascular permeability in lung 
ischemia/reperfusion injury [71, 72]. Several approaches may attenuate this alveolar- 
capillary dysfunction. For example, dimethylthiourea reduces postischemic 
microvascular dysfunction via its hydroxyl radical scavenger effects [73]. Hypoxia- 
inducible factor 1α (HIF-1α) controls endothelial function, but is downregulated in lung 
ischemia reperfusion injury. Stabilizing it can prevent endothelial dysfunction [74]. 
Sphingosine 1-phosphate (S1P) controls endothelial cell tight junctions and 
supplementation with this compound before reperfusion inhibits inflammatory cytokine 
production and improves oxygenation in murine lung ischemia/reperfusion [75]. 
Antibody targeting of αvβ5, an integrins that regulates endothelial permeability, also 
improved the postischemic oxygenation in a murine lung transplantation model [76]. 
 
 
3.3. Intravital fluorescence microscopy (IVM) 
 
The principle of fluorescence microscopy is that a distinct fluorescent dye can 
be rayed with light of a defined wavelength (excitation wavelength) and in response 
emits a quantum of light with a corresponding, different wavelength (emission 
wavelength) (Figure 3). This phenomenon is based on the fact that the excitation light 
transports energy. Distinct electrons on the fluorescent dye molecule adsorb photons 
and are thereby lifted to another energy level. This is an unstable condition and these 
electrons fall back into their original, lower energetic level immediately. This fall back 
liberates another quantum of energy, which is emitted as light. Because the liberated 




Figure 3: Schematic illustration of the excitation of a fluorescent dye on the atomic 
level. The schematic images show a molecule with a central atomic nucleus (large 
central black spot) encircled by three electron energy levels (blue circles). A) depicts 
the excitation of a resting electron on the second level (open spot) with fluorescent blue 
light. The concomitant energy transfer lifts the electron up to a higher energy level 
(filled spot). B) depicts the fact that the electron immediately loses this additional 
energy, falls back to a lower level and the originating slightly lower energy is emitted 
as fluorescent green light. 
 
 
Epi-illumination microscopy uses filter sets, which allow to differentiate 
between excitation and emission light (Figure 4). The light source (herein a mercury 
lamp) of the microscope emits light through an excitation filter, which absorbs the wide 
spectrum of light letting pass exclusively light of the defined excitation wave length. 
This virtually single-coloured light hits onto the fluorescent dye and provokes the 
emission of lower energetic excitation light, which is reflected back to a filter letting 
pass only light of the defined excitation wavelength. Reflected light of the excitation 









Figure 4: Schematic illustration of the principle of an epi-illumination fluorescence 
microscope. A: Light source; B: Filter for Excitation light; C: Beam splitter; D: 
Experiment object with fluorescent dye; E: Filter for Emission light; F: Camera 
 
 
IVM in experimental research on ischemia/reperfusion injury 
 
IVM has been utilized for the analyses of cell-cell interactions and 
microvascular dysfunction in a large array of experimental models. The use of this 
technique has allowed to understand the stepwise mechanisms of the leukocyte 
extravasation process during inflammation. For example, in hepatic injury, selectin- 
mediated leukocyte rolling was found to be a prerequisite for subsequent integrin- 
mediated firm adhesion of leukocytes [77]. Such fundamental and distinct roles of P- 
selectin and the integrin lymphocyte function associated antigen (LFA)-1 were directly 
visualized during in the postischemic microcirculation of the murine colon [78]. 
Postischemic vasoreactivity could be demonstrated in in the intestinal microcirculation 
as well [29]. In the murine striated cremaster muscle preparation, it was demonstrated 
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that chemokines regulate selectin-dependent neutrophil trafficking in a mast cell- 
controlled manner [79]. 
IVM of the thoracic organ microcirculation has been challenging, since 
tremendous physiologic movements elicited by the beating heart and the ventilated 
lungs have to be counterbalanced. Nevertheless, distinct experimental models have 
been elaborated to circumvent such hurdles and both the subepicardial coronary 
microcirculation of the heart and the subpleural pulmonary microcirculation of the lung 
could be visualized even in small animals as the mouse [80, 81]. In both latter organs, 
the sequential leukocyte extravasation cascade has been visualized. However, 
pulmonary ischemia/reperfusion injury has not been investigated so far by IVM in a 
rodent model. 
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4. Aim of the study 
 
Detailed understanding of the pathophysiological mechanisms underlying 
pulmonary ischemia/reperfusion injury are key to improve outcomes after lung 
transplantation clinically. Although circulating white blood cell recruitment and 
microvascular dysfunction during pulmonary ischemia/reperfusion injury have been 
investigated previously, evidence on the underlying mechanisms have been gathered 
mostly indirectly, experimentally and clinically. Further, results obtained from cell 
cultures and isolated organ perfusion experiments may not resemble the complex 
interplay of pathophysiological processes as in a live individual. 
The aim of the present study was it therefore to establish and validate an 
experimental approach which allows to study leukocyte recruitment and microvascular 
dysfunction within the pulmonary microcirculation during ischemia/reperfusion injury 
in a rodent model by means of intravital fluorescence microscopy. The experimental 
setup should also allow to monitor potential secondary organ dysfunction in the heart, 
liver and kidney by histopathological means. The experimental setup should be 
reproducible and provide an experimental basis for studies on experimental lung 
transplantation. 
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Female Lewis rats (Charles River) weighing 220-240g were used. The animals 
had free access to standard pellet food and tap water and were kept in 12h light and 12h 
dark cycles. All experiments were approved by the governmental ethical committee for 
animal experimentation and performed as the legislation on the protection of animals. 








Global anaesthesia was induced by intramuscular injection of a mixture of 
medetomidine (150 µg/kg body weight, Domitor), midazolam (2 mg /kg body weight, 
Dormicum) and fentanyl (5 µg/kg body weight, Fentanyl-Janssen) into the right 
quadriceps femoris muscle. 
The anesthetized animals were placed in a supine position for subsequent 
endotracheal intubation with a 16G catheter (Introcan Safety, Braun Melsungen AG, 
Melsungen, Germany) under direct vision. The catheter was then connected to small 
animal ventilator (Small animal ventilator KTR-5, Harvard Apparatus, Canada). 
Correct endotracheal intubation was additionally verified by synchronic expansion of 
the thoracic cage. The basic settings for the ventilator were settled to 75 strokes per 
minute with an inspiration/expiration ratio of 1 / 2. The air flow was adjusted to 0.5 
liters / min with a positive end-expiratory pressure of 9 cm H2O without additional 
oxygen supply. The respirator settings were adjusted throughout the experimentations 
based on arterial blood gas analyses. 
Central catheter implantation was performed as previously described [82]. 
Briefly, after intubation, an incision was made on the right paramedian aspect of the 
neck. of the rat, then the right external jugular vein and the right common carotid artery 
were exposed gently. The two vessels were secured proximally and distally by ordinary 
silk ordinary silk suture. Two central 20G catheters (BD Microlance, Becton Dickinson 
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S.A. Fraga, Huesca, Spain) were then inserted into the two vessels, flushed with saline 









2.2.2 Microsurgical procedures 
 
The lateral thoracotomy approach to the lung has been described in a murine 
model previously by Gielis et al [83]. After placement of the animal from the supine 
into the right lateral position, the chest wall was shaved gently. The incision was made 
beginning at the medial sternal side of the left rib cage and was followed along the 5th 
intercostal space directed to the spine. After disconnecting the endotracheal tube from 
the respirator, great care was taken when blunt penetration of the intercostal muscular 
layer was performed in order to avoid any alteration of the visceral pleural surface of 
the lung. Respiration was continued immediately after the thoracic cavity has been 
opened safely. The rib cage was spread open by placing two 1-0 holding sutures 
(Prolene, Polypropylen, Ethicon, USA) around the adjacent upper and lower ribs and 
pulling them gently towards the cranial and caudal directions. The lung tissue was 
moistened by temperature (37°C) saline regularly throughout the entire 
experimentation. A moistened cotton stick was used to gently move the pulmonary 
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tissue taking great care to not tough the ventral aspect of the lung, i.e. the region of 
interest for subsequent intravital fluorescence microscopy. The pulmonary ligament 
was cut off in order to get a better access to the lung hilum. Before clamping of the 
hilum for induction of ischemia, 125 I.U. of heparin (Rotexmedica, Trittau, Germany) 
was administered intravenously (i.v.). Clamping was performed by use of an ordinary 
microvascular vessel clamp (Figure 6). The lung and pleural cavity was kept moistened 





Figure 6: Macroscopic image of the surgical field during clamping of the left 
pulmonary hilum, i.e. during ischemia. 
 
 




The microsurgically equipped and prepared animals were transferred to the 
intravital microscope stage. Intravital fluorescence labelling of circulating leukocytes 
was established by i.v. injection of 0.5 ml of Rhodamine 6G (Molecular weight 479 Da; 
0.1 mg/ml, Sigma Chemicals). For plasma labelling, an injection of Fluoresceine Iso- 
Thyo-Cyanate (FITC)-Dextran (Molecular weight 150 kDa; 2 mg/ml, Sigma Chemicals) 
was injected via the central venous catheter. The moistened left lung surface was 
carefully covered with a horizontally positioned cover glass slip, which was fixed to a 
micromanipulator. The hydrostatic forces of the moistening saline attached the lung 
surface under the cover glass slip (Figure 7). The subpleural pulmonary 
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microcirculation of the left lung was visualized by a modified microscope (Zeiss, 
Oberkochen, Germany), which provides blue- (excitation wave length 490nm) and 
green-light (excitation wavelength 530nm) epi-illumination and is equipped with a 
filter set (Filter set 62HE, Colibri, Zeiss, Germany) to visualize the corresponding 
emission wave lengths of 510nm and 560nm, respectively. Water immersion lenses 
with a 10- and 20-fold magnification were used. All microscopic images were televised 








Figure 7: Schematic experimental setup for intravital fluorescence microscopy (IVM) 
of the rat pulmonary microcirculation. Animals were placed in a right-sided position on 
the microscope stage. Microscopic images were transferred to a computer-assisted 
image analysis system and saved onto a hard disc for subsequent off-line quantification 




Intravital fluorescence microscopy of the left lung subpleural pulmonary 
microcirculation was performed at three different time points, i.e. before induction of 
ischemia (T0), at 30min of Reperfusion (T1) and after 90 min of reperfusion (T2). At 
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least four different areas were analysed at each individual time point for at least 30 
seconds. 
Leukocyte endothelial cell adhesive interactions 
 
Firm leukocyte adhesion was defined as the number of intravascular leukocytes 
firmly attached for >15 seconds to the pulmonary microvascular endothelial cell lining 
of pulmonary arterioles and venules, given in cells / mm² endothelial surface. 
Leukocyte rolling was defined as the number of intravascular leukocytes loosely 
interacting with and rolling along the endothelial lining passing a reference point within 
pulmonary arterioles and venules during the observation period of 30 seconds, given in 
cells / min. 
Alveolar leukocyte recruitment 
 
The numbers of Rhodamine 6G-stained leukocytes within alveolar spaces were 
counted and are given as cells per high power field (HPF) [aU]. 
Macromolecular leakage 
The extravascular fluorescence intensity was measured within alveolar spaces 
after intravenous injection of the fluorescent dye FITC-dextrane at T0, T1, and T2. To 
account for different animal body weights and circulating blood volumes the individual 
measures at T1 and T2 were normalized by the intra-individual measurements at T0. 
Distance of air-filled alveolar spaces 
The distance of air-filled alveolar spaces is an indirect measure for interstitial 
pulmonary edema formation and is given in µm. 
Microvascular diameters 
 
The diameters of pulmonary terminal arterioles, alveolar capillaries and 
draining postcapillary venules are given in µm. 
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3.4. Histopathological analyses 
 
After completion of the experimental procedures and intravital microscopic 
analyses, i.e. after 90 min of pulmonary reperfusion (T2), both lungs, the heart, the 
kidneys and the livers were harvested for subsequent histopathological examination. 
The lungs were harvested by ligation and transection in inspiration. The other organs 
were harvested by transection of incoming and outgoing vessels. All organs were fixed 
in 4% paraformaldehyde overnight and were then stored in 80% ethanol until further 
processing. 
For routine hematoxylin-eosin staining, organ tissues were dehydrated in an 
ascending concentration of ethanol series and the ethanol was removed by aromatic 
hydrocarbon xylene. Afterwards all organs were embedded in paraffin wax and cut into 
4 μm thick layers with a microtome (Leica Biosystems, Germany) and fixed on a glass 
slide. The sections on the glass slips were dewaxed in a descending concentration of 
ethanol series and stained by haematoxylin and eosin in an ascending concentration of 
ethanol series. The basophilic structures were stained blue with haematoxylin, the 
acidophilic structures were stained red with eosin. 
The evaluation of the histological specimens were carried out by use of a light 
microscope (Zeiss, Oberkochen, Germany), which was connected to a digital camera 
(Zeiss, Oberkochen, Germany) and a corresponding computer-assisted software, the 
Axiovision (Zeiss, Oberkochen, Germany). 25 fields per slide were evaluated in each 
organ in 200× high-power-fields (HPFs). 
Pulmonary injury was semi-quantitatively analysed by using a lung injury score 
system, previously published by the American Thoracic Society Workshop [84] (Table 
1). Secondary organ damage to the kidney and liver were analysed quantifying the areas 
of tubular necrosis per HPF [85] and by use of the previously published Suzuki Score 






Score per field 
0 1 2 
















C. Hyaline membranes None 1 >1 








E. Alveolar septal thickening <2x 2x – 4x >4x 




Table 1: The Lung Damage Score for quantification of structural pulmonary injury. 







Score Congestion Vacuolization Necrosis 
0 None None None 
1 Minimal Minimal Minimal 
2 Mild Mild Mild 
3 Moderate Moderate Moderate 
4 Severe Severe Severe 
The level of damage was defined by planimetry in each high power field. Minimal = 0 




Table 2: The Suzuki Score system for quantification of structural liver injury. Adopted 
from [86]. 
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5.5. Statistical analysis 
 
Data are given as mean values ± standard error of the mean (SEM) and n 
represents the number of animals per experimental group and/or time point. Data was 
analysed using one-way analyses of variance (ANOVA) and corresponding post-hoc 
testing utilizing statistic computer software packages (SPSS 22, IBM, USA; SigmaStat, 
Jandel Scientific, USA). A value of probability of less than 0.05 was considered to 
indicate a statistically significant difference. 
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6. Results 
6.1. Intravital fluorescence microscopic imaging (IVM) 
During the learning curve, six animal preparations did not allow for the planned 
IVM observations. These animals had to be sacrificed because of technical failure, 
uncontrolled respiratory acidosis or insufficient exposure for intravital imaging. In a 
total of 8 animals, successful surgical preparation was followed by intravital 
fluorescence microscopic observation (IVM) of the pulmonary microcirculation before 
ischemia and at 30 min (T1) as well as 90 min of reperfusion (T2). 
The entire pulmonary microvascular tree could be visualized after contrast 
enhancement with FITC-Dextran including feeding pulmonary arterioles, alveolar 
capillaries and draining pulmonary venules (Figures 8-10). Pulmonary arterioles were 
differentiated from venules by the peripheral branching of blood flow and visible 
pulsatility. Venules were draining the blood from peripheral branches and did not show 




Figure 8: Intravital microscopic image of the pulmonary microcirculation in the left 
lung upper lobe. Contrast enhancement after intravenous injection of FITC-Dextran at 
90 min of reperfusion (T2). Blue arrows indicate the distributing and divergent blood 




Figure 9: Intravital microscopic image of the pulmonary microcirculation in the left 
lung upper lobe. Contrast enhancement after intravenous injection of FITC-Dextran 
prior to induction of ischemia (T0). The asterisk indicates an exemplary alveolar space 
surrounded by alveolar capillaries indicated by “C”. The red arrows indicates the blood 




Figure 10: Intravital microscopic image of the pulmonary microcirculation in the left 
lung upper lobe. Contrast enhancement after intravenous injection of FITC-Dextran 
prior to induction of ischemia (T0). Red arrows indicate the collecting blood flow from 
alveolar capillaries into a draining venule (V). Scale represents 20 µm. 
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Contrast enhancement with Rhodamine-6G allowed to visualize intravascular 
leukocytes and occasionally thrombocytes. Leukocytes were differentiated from 
thrombocytes based on their size difference. Visualized leukocytes were presumably 








Figure 11: Intravital microscopic image of the pulmonary microcirculation in the left 
lung upper lobe. Contrast enhancement after intravenous injection of Rhodamine 6G at 
90 min of reperfusion (T2). Red arrows indicate the collecting blood flow in a draining 
venule (V). The open arrow indicates an adherent leukocyte. The filled arrow indicates 
a group of intensely stained small thrombocytes. Scale represents 20 µm. 
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IVM – Parameters 
 
Leukocyte endothelial cell adhesive interactions 
 
IVM allowed for quantitative and qualitative analyses of leukocyte endothelial- 
cell adhesive interactions in the pulmonary microcirculation of the left lung surface. 
Rhodamine-6G stained leukocytes were interacting with the pulmonary vascular 
endothelium only in post-capillary venules. Virtually no adhesive interactions were 
observed in arterioles at any time point. In addition, interacting leukocytes were found 
to be firmly attached to the post-capillary venular endothelium (Figure 11). Rolling 








Figure 12: Firm leukocyte adhesion in post-capillary venules of the left lung 
pulmonary microcirculation. Data are given as mean values ± standard error of the 
mean and n represents the number of animals at the different time points, i.e. prior to 
induction of ischemia (T0), at 30 min of reperfusion (T1) and at 90 min of reperfusion 
(T2). The asterisk indicates a statistically significant difference when compared to T0 
(P<0.05). 
29  
Firm leukocyte adhesion was increasing from 117.14 ± 10.12 cells/mm 2 at T0 (prior to 
induction of ischemia) to 199.37 ± 15.03 cells/mm 2 at T1 (30min of reperfusion) and 
294.76 ± 13.31 cells/mm 2 at T2 (90 min of reperfusion). The difference between firm 
leukocyte adhesion at T0 and T2 was statistically significant (P=0.005; Figure 12). 
 
 
Alveolar leukocyte recruitment 
 
The numbers of Rhodamine-6G stained leukocytes within the alveolar spaces 
were 1.88 ± 0.17 [aU] at T0 (prior to induction of ischemia), 3.71 ± 0.21 [aU] at T1 
(30min of reperfusion) and 7.8 ± 0.49 [aU] at T2 (9 0 min of reperfusion). There were 
statistically significant differences between the alveolar space leukocyte counts 





Figure 13: Numbers of leukocytes within alveolar spaces the left lung. Data are given 
as mean values ± standard error of the mean and n represents the number of animals at 
the different time points, i.e. prior to induction of ischemia (T0), at 30 min of 
reperfusion (T1) and at 90 min of reperfusion (T2). * indicates a statistically significant 
difference when compared to T0 (P<0.05). # indicates a statistically significant 




The extravascular fluorescence intensity was measured within alveolar spaces 
after intravenous injection of the fluorescent dye FITC-dextrane at T0, T1, and T2. To 
account for different animal body weights and circulating blood volumes the individual 
measures at T1 and T2 were normalized by the intra-individual measurements at T0. 
The T1/T0 and T2/T0 ratios were 1.231 ± 0.018 [aU] and 1.408 ± 0.045 [aU]. The 








Figure 14: Macromolecular leakage in the left lung pulmonary microcirculation. To 
account for different animal body weights and circulating blood volumes the individual 
measurements of extravascular fluorescence intensity at T1 and T2 were normalized by 
the intra-individual measurements at T0. Data are given as mean values ± standard error 
of the mean and n represents the number of animals at the different time points. 
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Distance of air-filled alveolar spaces 
 
The distance of air-filled alveolar spaces is an indirect measure for interstitial 
pulmonary edema formation. The mean distances between air-filled alveolar spaces 
were 13.12 ± 0.33 µm at T0, 14.71 ± 0.32 µm at T1 and 15.78 ± 0.29 µm at T2. The 
differences between the individual time points were statistically not significant 




Figure 15: Distances between air-filled alveolar spaces given in µm. Data are given as 
mean values ± standard error of the mean and n represents the number of animals at the 
different time points, i.e. prior to induction of ischemia (T0), at 30 min of reperfusion 







The diameters of terminal pulmonary arterioles in the left lung surface, i.e. the 
final, capillary feeding arteriolar branches, did not relevantly change over the 
observation period. Arteriolar diameters were 15.81 ± 0.67 µm prior to induction of 
ischemia (T0), 14.46 ± 0.94 µm at 30 min of reperfusion (T1) and 14.17 ± 0.67 µm at 








Figure 16: Diameters of terminal pulmonary arterioles. Data are given as mean values 
± standard error of the mean and n represents the number of animals at the different 
time points, i.e. prior to induction of ischemia (T0), at 30 min of reperfusion (T1) and 





In addition to terminal arterioles, the diameters of third grade arterioles, i.e. two 
bifurcations further upstream of terminal arterioles (Figure 17), were analysed. The 
mean diameters of third grade arterioles in the left lung surface did not relevantly 
change over the observation period. Mean diameters of third grade arterioles were 23.78 
± 2.63 µm prior to induction of ischemia (T0), 21.96 ± 1.28 µm at 30 min of reperfusion 
(T1) and 19.61 ± 1.70 µm at 90 min of reperfusion (T2; Figure 18). The differences 
were statistically not significant. 
 
Figure 17: Intravital microscopic image of the pulmonary microcirculation in the left 
lung upper lobe. Contrast enhancement after intravenous injection of FITC-Dextran at 
90 min of reperfusion (T2). The diameter of the central pulmonary arteriolar vessel is 







Figure 18: Diameters of third grade pulmonary arterioles. Data are given as mean 
values ± standard error of the mean and n represents the number of animals at the 
different time points, i.e. prior to induction of ischemia (T0), at 30 min of reperfusion 
(T1) and at 90 min of reperfusion (T2). 
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The alveolar capillary diameter in the left lung surface did not relevantly change 
over the observation period. Mean diameters of pulmonary alveolar capillaries were 
5.30 ± 0.13 µm prior to induction of ischemia (T0), 5.72 ± 0.18 µm at 30 min of 
reperfusion (T1) and 5.63 ± 0.11 µm at 90 min of reperfusion (T2; Figure 19). The 




Figure 19: Diameters of alveolar capillaries. Data are given as mean values ± standard 
error of the mean and n represents the number of animals at the different time points, 
i.e. prior to induction of ischemia (T0), at 30 min of reperfusion (T1) and at 90 min of 
reperfusion (T2). 
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The diameters of postcapillary pulmonary venules in the left lung surface did 
not relevantly change over the observation period. Postcapillary venular diameters were 
20.04 ± 0.85 µm prior to induction of ischemia (T0), 18.47 ± 0.71 µm at 30 min of 
reperfusion (T1) and 16.51 ± 0.62 µm at 90 min of reperfusion (T2; Figure 20). The 





Figure 20: Diameters of post-capillary pulmonary venules. Data are given as mean 
values ± standard error of the mean and n represents the number of animals at the 
different time points, i.e. prior to induction of ischemia (T0), at 30 min of reperfusion 
(T1) and at 90 min of reperfusion (T2). 
 
 
6.2. Histopatholoic analyses 
 
Histopathology of the lungs 
 
The histopathologic analysis of lung tissue specimens harvested after 90 min of 
reperfusion (at T2), indicated mild damage to the pulmonary parenchymal tissue 
architecture. Figure 21 shows a high power field of a histopathologic specimen of a left 
lung harvested at T2 with mild alveolar septal thickening and some leukocytic 
infiltrations. As an internal control, Figure 22 shows a high power field of a 




Figure 21: Exemplary histological specimen of a left lung, harvested after 90min of 
reperfusion (T2). Routine hematoxylin-eosin staining. Scale bar represents 
approximately 20µm. 
 
Figure 22: Exemplary histological specimen of a right lung, harvested after 90min of 
reperfusion (T2). Routine hematoxylin-eosin staining. Scale bar represents 
approximately 20µm. 
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The mean lung damage scores were 0.73 ± 0.03 [aU] and 0.61 ± 0.08 [aU] in 
left and right lung samples harvested at 90 min of reperfusion (T2), respectively. The 







Figure 23: Lung injury Scores in left and right lung tissue specimens harvested after 
left-sided 30 min of ischemia and 90 min of reperfusion (T2). Data are given as mean 
values ± standard error of the mean and n represen ts the number of experiments. The 
asterisk indicates a statistically significant difference (P<0.05). 
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Histopathology of the heart 
 
The histopathologic analysis of cardiac tissue specimens harvested after 90 min 
of pulmonary reperfusion (at T2) showed a normal architecture of the myocardium 
(Figure 24), indicating no relevant effect of pulmonary ischemia/reperfusion injury on 
the myocardium at this time point. 
 
Figure 24: Histological specimen of the heart, harvested after 90min of pulmonary 
reperfusion (T2). Routine hematoxylin-eosin staining. Scale bar represents 
approximately 20µm. 
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Histopathology of the kidney 
 
The histopathologic analysis of kidney tissue specimens harvested after 90 min 
of pulmonary reperfusion (at T2) showed a vastly normal architecture (Figure 25), 
indicating no relevant effect of pulmonary ischemia/reperfusion injury on the kidney 
microarchitecture at this time point. 
 
Figure 25: Histological specimen of a kidney harvested after 90min of pulmonary 
reperfusion (T2) showing relatively undisturbed tubular cellular architecture. Routine 
hematoxylin-eosin staining. 
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Histopathology of the liver 
 
The Suzuki Score [86]was used to semi-quantitatively quantify the secondary 
organ damage in the liver following pulmonary ischemia/reperfusion injury. 
Hepatocyte necrosis was not found in none of the liver specimens analysed. Instead, 







Figure 26: Histological specimen of a liver harvested after 90min of pulmonary 
reperfusion (T2) showing intense hepatocytic vacuolization. Routine hematoxylin- 
eosin staining. Scale bar represents approx. 20 micrometers. 
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Semi-quantitative analyses revealed a mean Suzuki Score for hepatocytic 






Figure 27: Secondary organ damage in the liver after pulmonary ischemia/reperfusion. 
Semi-quantitative histopathologic analysis was performed using the Suzuki-Score [ref], 
assessing hepatocytic congestion and vacuolization in liver specimens harvested at 90 
min of pulmonary reperfusion (T2). Data are given as mean values ± standard error of 






This study established an experimental approach to analyse cellular interactions 
and microcirculatory dysfunction during pulmonary ischemia/reperfusion injury by 
intravital fluorescence microscopy in the rat. While the experimentation of large 
experimental animals is appealing also in view of mimicking the human situation, it is 
challenging because of the demanding logistic efforts (housing, anaesthesia etc.). Small 
animal models are therefore preferred. Moreover, molecular targeting by genetic 
knock-out or knock-in techniques or pharmaco-immunological measures such as 
specific antibody treatment are well established and dramatically cheaper in rodents. 
Nevertheless, surgical preparation of the experimental animals and transplantation of 
solid organs for example in rodents is seemingly different from the larger experimental 
animal and human situations demanding meticulous microsurgical training and 
experience [87]. 
Experimental studies on pulmonary ischemia/reperfusion injury have been 
carried out in a large variety of animal models, e.g. in mice, rats, rabbits, dogs and sheep 
[36, 52, 70, 88, 89]. Some of these studies also investigated pulmonary 
ischemia/reperfusion injury and experimental lung transplantation. For example, early 
experimental works on lung transplantation analysed the effects of distinct lung graft 
inflation statuses during preservation [90-93]. Such insights in the relationship between 
graft inflation during procurement as well as transportation and post-transplant lung 
graft function have led to the generally accepted and practiced concept of clinical lung 
transplantation, harvesting and transporting lung allografts in a mild to moderately 
inflated state. 
Many of the experimental studies on pulmonary ischemia/reperfusion injury 
intended to focus on microvascular dysfunction. A large variety of experiments 
indirectly assessed for example post-ischemic neutrophil accumulation in the lung by 
quantification of myeloperoxidase tissue content. Intravital fluorescence microscopy 
(IVM) has been extensively used and is a well established experimental and clinical 
means to observe and analyse microcirculatory phenomena under physiological and 
pathophysiological conditions in a large variety of organs [29, 77, 80, 94-96]. IVM of 
the thoracic organs is challenging because of the constant need for counterbalancing 
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the movements of the ventilated lung and the pulsations of the beating heart [97]. 
Kreisel and co-workers have used a veterinary glue to attach a cover glass onto the lung 
surface and found that neutrophil extravasation was monocyte-dependent in a 
challenging murine lung transplantation model [98]. However, the glue itself and/or the 
shear forces exerted by the moving lung after sticking to the glass slip may provoke 
distinct inflammatory responses affecting the pulmonary microcirculation apart from 
the desired pathophysiological setting of interest. Bennewitz et al. stabilized the lung 
surface by use of a specific suction system and analysed neutrophil and red blood cell 
trafficking in the pulmonary microcirculation in a model of sickle cell disease in mice 
[99]. Just as in the “glued lung”, there is some concern about potential extra shear force- 
induced “ventilator injury” in this approach [100]. Tabuchi et al. established a plateau 
phase at the end of the inspiration phase yielding a lung motion stop for 300ms before 
continuation with the respiratory cycle and thereby analysed the murine pulmonary 
microcirculation [101]. The herein used method also intended to establish an approach 
minimizing shear stress to the lung surface and excluding other toxic side effects 
potentially elicited by a glue. Access of the rat’s left lung subpleural pulmonary 
microcirculation for IVM was established as previously published in a murine model 
[102]. We used a cover glass slip that was fixed horizontally over the exposed lung 
surface by means of a micromanipulator. The level of the cover glass defined a stable 
focus level for the microscopic observations. The lung was attached to the lower side 
of the glass solely by hydrostatic forces after moistening its surface with warm 
physiological saline solution supported by a positive end-expiratory pressure level of 
9mmHg [102]. Only horizontal excursions of the lung during inspiration and expiration 
were observed, but these did not hinder continuous visualization of the subpleural 
pulmonary microcirculation. Pulsations of the beating heart were found to be negligible 
choosing a target area in the lower lobe of the left lung. Supporting this technique, we 
had established this approach for IVM of the coronary microcirculation in rodents 
before [80, 103] 
Despite all the technical advances, the use of IVM for studies on physiological 
and pathophysiological microcirculatory phenomena has some shortcomings. 
Obviously, there is a certain amount of surgical trauma that cannot be prevented for the 
exposure of the lung surface. It can only be minimized by refined microsurgical 
techniques. Direct manipulation of the target tissue must be omitted and the organs 
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surfaces must be kept moistened with temperature saline during the entire 
experimentation [104]. The experimental setup used herein is restricted for the acute 
experiment only. However, even though closure of the chest may be established, one 
has to consider that IVM of the lung surface at later time points after re-opening the 
chest may be hindered by ingrowth of adhesion tissues. 
The use of fluorescent dyes such as FITC-dextrane or Rhodamine 6G may elicit 
a certain inflammatory and/or thrombogenic photo-toxic effect. This may be elicited by 
heat or induction of reactive oxygen species, both directly linked to the fluorescent light 
[105]. In fact, by extending the observation period, i.e. the tissue radiation with 
fluorescent light, Lindberg et al. could provoked platelet aggregation in in the cremaster 
muscle preparation after injection of FITC dextrane [106]. Not only FITC dextrane, but 
also the use of Rhodamine 6G and extensive tissue exposure to fluorescent light may 
elicit platelet activation, endothelial cell damage, arteriolar vasospasm and leukocyte- 
endothelial cell interactions [107]. The photo-toxic effect may be used experimentally 
to study thrombogenesis in vivo [108]. Although it could not be eliminated, the photo- 
toxicity may not have relevantly affected the analyses in this present investigation, 
because the exposure of the lung surface to fluorescent light was kept to a minimum of 
only 20-30 seconds for the recording of the distinct regions of interest. Notably, 
visualization of clear-cut photo-toxic effects on the microcirculation may only be 
obtained after long exposure times and abnormally high light doses [109]. 
The experimental setup used in this investigation allows to visualize the 
pulmonary microcirculation of the rat in vivo under physiological conditions and after 
ischemia during reperfusion. The spatial and temporal resolution of the televised 
imaging enabled to analyse the circulation of blood through all segments of the rat’s 
left lung subpleural pulmonary microcirculation. Using this approach, it is possible to 
clearly distinguish feeding pulmonary arterioles, alveolar capillaries and draining 
pulmonary post-capillary venules. We detected an inflammatory effect elicited by 30 
minutes of pulmonary ischemia, i.e. IVM revealed an increase in leukocytic 
sequestration in the pulmonary microcirculation. In fact, there was a significant 
elevation of firmly attached leukocytes on the microvascular endothelium of post- 
capillary pulmonary venules as well as significantly increased numbers of sequestered 
leukocytes in pulmonary alveoli at 90 minutes of reperfusion. It needs to be noted that 
the lungs underwent 30 minutes of warm ischemia. Of course, this does not perfectly 
46  
mimic a lung transplantation model, but it offers to evaluate the true effect of ischemia 
on the pulmonary microcirculation, irrespective of any inflammatory reactions evoked 
by cooling and rewarming of a transplanted lung graft. The latter could be differentiated 
best by using a syngeneic transplantation approach, i.e. the transplantation of lungs 
between genetically identical individuals [110]. In addition, the herein presented 
approach allows to study pulmonary ischemia/reperfusion injury free of any cognate 
immune reactions as they cannot be excluded in an allogeneic transplantation model, 
i.e. the transplantation of a lung between genetically different individuals of the same 
species [111]. Importantly, using the rat model appeared advantageous over a murine 
approach perspectively, because reproducibility of a murine lung transplantation is 
extremely difficult [112] and the rat may serve as a well established recipient when 
small animal xenotransplantation studies are intended, i.e. the transplantation of organs 
between individuals of different species. In fact, our group has recently published IVM 
studies of the coronary microcirculation in a hamster-to-rat heart transplantation model 
[82]. It has therefore been intriguing to establish an experimental basis for subsequent 
analyses of microvascular dysfunction in xenogeneic lung transplantation in a rodent 
model. 
Microcirculatory dysfunction or a “no-reflow” phenomenon during reperfusion 
could not be delineated in the present study. Underlining this, there were no relevant 
alterations of microvascular diameters, neither in pulmonary terminal arterioles, 
alveolar capillaries nor post-capillary venules. Hence, a vasoreactive response 
following the ischemic period was not detected. In fact, the pulmonary microvascular 
blood flow remained relatively high. The timely resolution of the used image analyses 
software did not allow to determine blood flow velocities in the pulmonary 
microvessels, although this setup has been routinely used in other IVM settings [113, 
114]. On one hand, the ischemic period may have been simply too short to elicit 
profound microcirculatory dysfunction during reperfusion. On the other hand, the 
observation period during reperfusion of the previously ischemic lung may have been 
too short to detect it. Sack and co-workers used a large animal lung transplantation 
model and found significant increases in pulmonary vascular resistance and reduced 
red blood cell flow velocities after 4 hours of cold ischemia and 6 hours of reperfusion 
[115]. IVM was used in a rabbit model of 1 hour of ischemia in the lung and the authors 
found reduced perfusion in alveolar capillaries and larger pulmonary microvessels after 
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10 min and 1 hour of reperfusion, respectively [62]. However, there was detectable 
microcirculatory dysfunction and inflammation during ischemia/reperfusion injury in 
the hamster-to-rat cardiac xenotransplantation model after comparable ischemic and 
reperfusion times as used in the present study[82]. The latter discrepancy very likely 
reflects the fact that the lung is more tolerant to ischemia than the heart or brain [116, 
117]. As the lung is fed by arterial blood derived from the systemic circulation through 
bronchial arteries, one has to consider also that post-ischemic vasoreactivity may also 
occur in these vessels, which were inaccessible for epi-illumination IVM of the pleural 
lung surface. The lung is of entodermal origin and therefore it remains to be determined 
whether the bronchial arteries may have the potential to mimic the hepatic arterial 
buffer response [118]. 
Despite the lack of post-ischemic vasoreactions, there was a clearly detectable 
leukocytic response to the 30 minutes ischemic period during reperfusion. Significantly 
elevated numbers of Rhodamine 6G-stained leukocytes firmly attached to the 
pulmonary post-capillary venular endothelium and sequestered in the alveolar spaces 
at 90 minutes of reperfusion. Due to the polymorphonuclear staining characteristics of 
the interacting white blood cells, the present data underline previous findings 
suggesting that neutrophils play a significant role during pulmonary 
ischemia/reperfusion injury. Eppinger and colleagues analyzed the neutrophil 
sequestration in lung ischemia/reperfusion injury indirectly by measuring the 
pulmonary tissue content of myeloperoxidase [52]. They found significant neutrophil 
sequestration in reperfused rat lungs after 4 hours. Thus, the herein observed leukocytic 
response might have been even more pronounced in later reperfusion phases. Zhang et 
al., for example, quantified lung tissue neutrophil content by quantification of 
myeloperoxidase content 4 hours after Staphylococcal M1-protein induced pulmonary 
injury [119]. Interestingly, the data by Eppinger et al. suggest that there is a preceding 
inflammatory phase, independent of neutrophils and characterized by increased 
pulmonary vascular permeability early (30 minutes) during reperfusion [52]. They 
suggested that this early inflammation is driven by macrophages and the secretion of 
inflammatory mediators such as tumor necrosis factor (TNF)-alpha, interferon gamma 
and monocyte chemoattractant protein-1 [53]. Only TNF-alpha was involved in the 
neutrophil-dependent late inflammation phase and TNF-alpha is well known to provoke 
inflammatory neutrophil recruitment [77, 79, 120, 121]. It is interesting to note, that in 
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contrast to the findings by Eppinger et al., we found no evidence for an ischemia- 
induced increase in pulmonary microvascular permeability, despite the leukocytic 
response observed. Herein, macromolecular leakage and distances between alveolar 
spaces remained unaltered during reperfusion. The present findings, however, do not 
exclude the presence of macrophage-driven early post-ischemic permeability changes. 
The relative molecular weight of FITC-dextran is 150kDa and this dye may therefore 
be less effective in detecting mild pulmonary oedema formation, although it has been 
effectively used in other settings to quantify microvascular permeability [113, 122]. 
Again, the relatively small insult of only 30 minutes of ischemia may explain why 
vascular permeability changes might have been relatively small and were not detectable 
herein by IVM. The histopasthological assessment and calculation of the lung damage 
score underline the latter notion. The detected lung tissue injury scores were found to 
be relatively low, although there was at least some degree of pulmonary edema detected 
from the histopathological analyses. However, there were virtually no hyaline 
membranes or proteinaceous debris within alveoli found, both of which are features in 
the clinical scenario of lung injury, but hardly found in animal models [123]. Looking 
at the semi-quantitative measures of the lung injury score, it seems less sensitive to 
detect mild pulmonary injury in animal models of lung injury [84]. 
Finding a leukocytic response to an ischemic insult in the reperfused lung 
microcirculation is per se not surprising as this is a general phenomenon observed in 
many other post-ischemic and reperfused organs [46-49]. Leukocyte influx is a feature 
of inflammation in general and neutrophils play a central role[124]. Also in the lung, 
neutrophil accumulation has been found in several inflammatory settings [102, 125, 
126]. However, data on inflammatory leukocyte recruitment in the lung has to be 
interpreted carefully in view of the so-called “marginated pool” of leukocytes in the 
lung [127]. Even under normal and physiological conditions, there resides a large pool 
of leukocytes in the pulmonary tissue and this is different to other organs. It has been 
speculated that the passage of circulating leukocytes through alveolar capillaries is 
delayed because of the relatively small alveolar capillary diameters, therefore 
increasing the net lung tissue content of leukocytes under physiological conditions [63, 
128, 129]. 
Although bronchial arteries are not accessible for IVM of the pleural surface of 
the lung, IVM is an effective mean to study the post-ischemic leukocyte infiltration into 
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the pulmonary tissue. Unaffected by the “marginated pool”, intravascular leukocyte- 
endothelial cell adhesive interactions can be visualized and quantified directly, as has 
also been reported previously [62, 102, 130, 131]. It cannot be excluded that circulating 
leukocytes may be recruited to the post-ischemic lung tissue by extravasation from 
bronchial arteries, but it is generally held that arterial vessels are not the prime location 
for inflammatory leukocyte recruitment [132, 133]. Only very small amounts of 
leukocytes may interact with arterial endothelium and that requires massive 
inflammatory stimulation when compared to venular endothelium. For example, after  
a local challenge with a relatively high-dosed cocktail of TNF-alpha and interleukin-1, 
mild leukocyte-endothelial cell adhesion occurred arteries, mediated by the integrin 
lymphocyte function-associated antigen (LFA)-1[120]. In contrast to the relatively low 
response on the arterial endothelium, neighbouring venular endothelium was almost 
fully covered with adherent cells (unpublished data). The lesser leukocyte response in 
arteries may be explained by the fact that corresponding ligands for integrins, such as 
LFA-1, are only poorly expressed on arterial endothelium[133]. Even in atherosclerosis, 
it has been suggested that the vasa vasorum network (including venules) within the 
vessel wall of arteries are key players in the initiation and progression of this 
inflammatory vascular disease [134]. Circulating leukocytes may also be hindered to 
adhere to arterial endothelium because of the strikingly distinct shear rates in the arterial 
blood stream [133]. But it needs to be noted that blood flow in the low-pressure 
pulmonary arterial circulation differs tremendously from the systemic circulation. It 
was found herein that post-ischemic leukocyte-endothelial cell interactions take place 
primarily in postcapillary pulmonary venules, but not in pulmonary arterioles. This is 
in contrast to previous IVM studies on inflammatory leukocyte recruitment in the lung 
showing leukocyte endothelial cell adhesive interactions in both pulmonary arterioles 
and venules [102]. Others also observed rolling leukocytes in pulmonary microvessels, 
in both arterioles and venules [62, 125] . It can only be speculated at present whether 
the relatively small ischemic insult used herein may not allow to detect rolling 
interactions but only firm adhesion, which has to be considered to be a cumulative 
phenomenon in contrast to rolling. 
Remote organ injury has been reported in several organs. For example, 
myocardial oedema formation and necrosis occur secondary to renal or hepatic 
ischemia/reperfusion injury [135]. Moderate acute kidney injury has been observed 
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during hepatic ischemia/reperfusion injury [136]. In turn, hepatic remote injury was 
observed after 30 minutes of intestinal ischemia and 90 minutes of reperfusion, 
presenting histopathologically with hepatocyte cytoplasmic clod formation, 
vacuolization and sinusoidal congestion [29]. Mechanistically, circulating 
inflammatory mediators derived from the primarily injured tissue and provided through 
a systemic inflammatory response elicit the injury in remote organs [137]. Herein, we 
found only mild hepatic affection after pulmonary ischemia and reperfusion, but no 
histopathological findings were obtained from cardiac and renal specimens. Potential 
reason is the only mild pulmonary ischemic insult, as discussed above. Nevertheless, 
despite the inflammatory response, remote organ injury during pulmonary ischemia and 
reperfusion may also be elicited hemodynamically. During lung transplantation, for 
example, clamping of one lung hilum leads to redirection of the entire cardiac output 
through only “half” of the pulmonary vascular bed. Although the pulmonary arteries 
are capacity vessels and may compensate volume overload through dilatation quite 
impressively under normal physiologic conditions, this function may be dramatically 
impaired in terminal lung diseases, which reason transplantation. In fact, end-stage lung 
disease patients frequently present with secondary pulmonary hypertension and 
therefore about 36% of lung transplantation procedures require the intraoperative use 
of extracorporeal circulation techniques in order to prevent acute right heart dilatation, 
congestion and ultimately failure [138]. 
Taken together, the presented experimental approach provides a basis for the 
experimental study of pulmonary ischemia/reperfusion injury by IVM in the rat. The 
experimental setup has been validated to study the entire subpleural pulmonary 
microcirculation before the induction of ischemia and during reperfusion. Future work 
on the microvascular dysfunction in the rat pulmonary ischemia/reperfusion injury 
model will have to focus more in detail on the ischemic time-reperfusion injury 
response relationship. However, IVM appears to be reliably used to study the 
pulmonary microcirculation in rats in experimental lung transplantation in the 
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